AdvisorShares Pure US Cannabis ETF (MSOS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AdvisorShares Pure US Cannabis ETF (MSOS) trades at $4.58 with AI Score 44/100 (Grade C). AdvisorShares Pure US Cannabis ETF (MSOS) is an actively managed ETF focusing on U. S. cannabis companies, providing easy access to this growing market. Market cap: $594.19M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for MSOS: MSOS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MSOS against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MSOS: the 1 perspectives are evenly split.
How is this calculated? →AdvisorShares Pure US Cannabis ETF (MSOS) Financial Services Profile
AdvisorShares Pure US Cannabis ETF (MSOS) offers investors exposure to U.S. cannabis companies, including multi-state operators, through a U.S.-listed, actively managed ETF. Trading on the NYSE Arca, MSOS provides a convenient way to access the U.S. cannabis market, which can be difficult to navigate directly.
What Is the Investment Thesis for MSOS?
MSOS presents an investment opportunity in the expanding U.S. cannabis market, driven by increasing state-level legalization and growing consumer acceptance. With a beta of -0.14, MSOS exhibits low correlation to the broader market. The ETF's active management allows it to adapt to regulatory changes and capitalize on emerging opportunities within the sector. Key value drivers include the continued expansion of legal cannabis markets in the U.S. and potential federal policy reforms. However, investors should be aware of the risks associated with the cannabis industry, including regulatory uncertainty and market volatility. The ETF's performance is directly tied to the performance of U.S. cannabis companies, making it sensitive to changes in market sentiment and regulatory developments.
Based on FMP financials and quantitative analysis
MSOS Key Highlights
- MSOS is the first U.S.-listed ETF to focus exclusively on U.S. cannabis companies, providing a unique investment vehicle.
- The ETF is actively managed, allowing for strategic allocation across a diverse range of cannabis-related businesses.
- MSOS trades on the NYSE Arca exchange, offering easy access to U.S. cannabis exposure through a single trade.
- The ETF's assets are held by BNY Mellon, a major U.S. custodial bank, ensuring security and regulatory compliance.
- MSOS has a market cap of $594.19M, reflecting significant investor interest in U.S. cannabis opportunities.
Who Are MSOS's Competitors?
MSOS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVLC Avantis U.S. Large Cap Equity ETF | $89.80 | +0.68% | $1.27B | 47 |
| BBEM JPMorgan BetaBuilders Emerging Markets Equity ETF | $78.05 | +3.09% | $881.96M | 47 |
| ECH iShares MSCI Chile ETF | $39.54 | +1.05% | $1.06B | 47 |
| GWX State Street SPDR S&P International Small Cap ETF | $44.24 | +1.00% | $924.63M | 47 |
| IVES Dan Ives Wedbush AI Revolution ETF | $38.15 | +2.33% | $911.74M | 44 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MSOS's Key Strengths?
- First U.S.-listed ETF focused exclusively on U.S. cannabis companies.
- Actively managed portfolio with experienced portfolio managers.
- Easy access to the U.S. cannabis market through a single ETF.
- Assets held by a major U.S. custodial bank (BNY Mellon).
What Are MSOS's Weaknesses?
- Concentrated exposure to the U.S. cannabis industry, which is subject to regulatory uncertainty.
- Performance is highly dependent on the performance of U.S. cannabis companies.
- Expense ratio may be higher than passively managed ETFs.
- Beta of -0.14 may not appeal to all investors.
What Could Drive MSOS Stock Higher?
- Continued state-level cannabis legalization driving market expansion.
- Potential federal cannabis policy reform, such as decriminalization or legalization.
- Expansion of cannabis-related businesses and product innovation.
- Increased institutional investment in the cannabis sector.
What Are the Key Risks for MSOS?
- Regulatory uncertainty and potential changes in cannabis laws.
- Increased competition from other ETFs and investment vehicles.
- Market volatility and fluctuations in cannabis company valuations.
- Negative public perception of the cannabis industry.
- Changes in consumer preferences and demand for cannabis products.
What Are the Growth Opportunities for MSOS?
- Increased State Legalization: The ongoing trend of state-level cannabis legalization presents a significant growth opportunity for MSOS. As more states legalize cannabis for medical or recreational use, the market for U.S. cannabis companies will expand, driving demand for MSOS. Each new state market represents a potential revenue stream for the companies held within the ETF, increasing their value and MSOS's overall performance. This growth is expected to continue over the next 3-5 years as more states consider legalization measures.
- Potential Federal Policy Reform: Federal cannabis policy reform, such as decriminalization or legalization, could be a major catalyst for the U.S. cannabis industry. Such reforms would remove significant regulatory hurdles, allowing cannabis companies to operate more freely and access traditional financial services. This would likely lead to increased investment in the sector and higher valuations for cannabis companies, benefiting MSOS. While the timing of federal reform is uncertain, it remains a significant long-term growth opportunity.
- Expansion of Cannabis-Related Businesses: The cannabis industry is evolving beyond cultivation and retail to include a wide range of related businesses, such as technology, branding, and ancillary services. MSOS can capitalize on this trend by investing in companies that provide innovative solutions and support the growth of the cannabis ecosystem. This diversification can reduce risk and enhance returns for the ETF. The market for cannabis-related businesses is expected to grow rapidly over the next decade.
- Increased Institutional Investment: As the cannabis industry matures and becomes more mainstream, institutional investors are likely to increase their exposure to the sector. MSOS provides a convenient and regulated way for institutions to invest in U.S. cannabis companies. Increased institutional investment would drive demand for MSOS shares and potentially lead to higher valuations for the ETF. This trend is expected to accelerate as regulatory uncertainty diminishes and the industry gains greater legitimacy.
- Product Innovation and Market Expansion: U.S. cannabis companies are continuously innovating and developing new products and services to meet evolving consumer preferences. This includes new strains, consumption methods, and product formats. MSOS can benefit from this innovation by investing in companies that are at the forefront of product development and market expansion. The market for cannabis products is expected to grow significantly over the next decade, driven by product innovation and increasing consumer acceptance.
What Opportunities Does MSOS Have?
- Increased state-level cannabis legalization.
- Potential federal cannabis policy reform.
- Expansion of cannabis-related businesses and product innovation.
- Increased institutional investment in the cannabis sector.
What Threats Does MSOS Face?
- Regulatory uncertainty and potential changes in cannabis laws.
- Competition from other ETFs and investment vehicles.
- Market volatility and fluctuations in cannabis company valuations.
- Negative public perception of the cannabis industry.
What Are MSOS's Competitive Advantages?
- First-mover advantage as the first U.S.-listed ETF focused exclusively on U.S. cannabis companies.
- Active management allows for strategic allocation and adaptation to market changes.
- Easy access to the U.S. cannabis market through a single, liquid ETF.
- Reputation and expertise of the portfolio manager in the cannabis industry.
What Does MSOS Do?
AdvisorShares Pure US Cannabis ETF (MSOS) is the first actively managed U.S.-listed exchange-traded fund dedicated to investing exclusively in U.S. cannabis companies. Launched to provide investors with easy access to the burgeoning U.S. cannabis market, MSOS focuses on multi-state operators and other businesses operating within the cannabis ecosystem. The ETF trades on the NYSE Arca exchange, offering a single point of access to a diverse portfolio of cannabis securities. Before MSOS, investors seeking exposure to U.S. cannabis companies often had to navigate smaller, foreign exchanges, making the process more complex and potentially riskier. MSOS simplifies this process by consolidating multiple cannabis-related investments into a single, actively managed fund. The portfolio manager utilizes their expertise in capital markets and regulated industries to allocate assets across the investable universe of U.S. cannabis companies. MSOS's assets are held by BNY Mellon, a major U.S. custodial bank, providing an additional layer of security and trust for investors. The ETF's active management strategy allows for dynamic adjustments to the portfolio based on market conditions and regulatory developments within the rapidly evolving cannabis industry.
What Products and Services Does MSOS Offer?
- Invests in a diversified portfolio of U.S. cannabis companies.
- Provides investors with easy access to the U.S. cannabis market through a single ETF.
- Actively manages the portfolio to adapt to market conditions and regulatory changes.
- Trades on the NYSE Arca exchange, offering liquidity and transparency.
- Focuses exclusively on U.S. companies, including multi-state operators.
- Offers exposure to a variety of cannabis-related businesses, including cultivation, processing, and retail.
- Utilizes the expertise of experienced portfolio managers with a deep understanding of the cannabis industry.
How Does MSOS Make Money?
- MSOS generates revenue through management fees charged to investors.
- The ETF's performance is directly tied to the performance of its underlying holdings.
- Active management aims to outperform a passive benchmark by strategically allocating assets.
- The ETF's expense ratio covers the costs of managing the portfolio and operating the fund.
What Industry Does MSOS Operate In?
MSOS operates within the asset management industry, specifically focusing on the cannabis sector. The U.S. cannabis market is experiencing rapid growth, driven by increasing legalization and consumer demand. However, the industry faces regulatory challenges and market volatility. MSOS provides a way for investors to participate in this growth while mitigating some of the risks associated with individual stock picking. The competitive landscape includes other ETFs and investment vehicles that offer exposure to the cannabis industry, but MSOS differentiates itself by focusing exclusively on U.S. companies and employing an active management strategy.
Who Are MSOS's Key Customers?
- Retail investors seeking exposure to the U.S. cannabis market.
- Institutional investors looking for a convenient and regulated way to invest in the sector.
- Financial advisors seeking to diversify client portfolios with cannabis-related assets.
- High-net-worth individuals interested in participating in the growth of the cannabis industry.
AdvisorShares Pure US Cannabis ETF (MSOS) Valuation Context
Relative to its peer group, MSOS's quantitative score of 44/100 is roughly in line with the peer average of 46/100.
MSOS Financials
Bull Case vs Bear Case
Bull Case
- Momentum is building for federal cannabis reform, even incremental steps could boost MSOS.
- Major players are positioning for US expansion, suggesting long-term confidence in the market.
- Social sentiment is shifting as more states legalize, reducing the stigma around cannabis.
- MSOS offers diversified exposure to the US cannabis market, mitigating risk compared to single-stock plays.
Bear Case
- Regulatory hurdles remain significant, and federal legalization is not guaranteed.
- Competition is intensifying as more companies enter the cannabis space.
- Market sentiment can be volatile, influenced by political and economic uncertainties.
- Operational challenges and financial losses are common among cannabis companies, impacting MSOS performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MSOS Latest News
-
Trulieve Makes History As First US Cannabis Stock On NYSE
benzinga · Jun 10, 2026
-
Trulieve Makes History as the First US Cannabis Company to Trade on the NYSE
Yahoo! Finance: MSOS News · Jun 10, 2026
-
MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?
Yahoo! Finance: MSOS News · Jun 9, 2026
-
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
benzinga · Jun 5, 2026
MSOS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MSOS.
Price Targets
Wall Street price target analysis for MSOS.
MSOS MoonshotScore
What does this score mean?
The MoonshotScore rates MSOS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Trulieve Makes History As First US Cannabis Stock On NYSE
Trulieve Makes History as the First US Cannabis Company to Trade on the NYSE
MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
MSOS Financial Services Stock FAQ
What does AdvisorShares Pure US Cannabis ETF do?
AdvisorShares Pure US Cannabis ETF (MSOS) is an actively managed fund that invests exclusively in U.S. cannabis companies. It provides a convenient way for investors to gain exposure to the rapidly growing U.S. cannabis market without having to individually select and manage a portfolio of cannabis stocks. The ETF focuses on companies involved in various aspects of the cannabis industry, including cultivation, processing, and retail. By investing in MSOS, investors can participate in the potential growth of the U.S. cannabis market while diversifying their risk across multiple companies.
What do analysts say about MSOS stock?
Analyst coverage of MSOS is still developing, reflecting the evolving nature of the cannabis industry. Generally, analysts recognize the growth potential of the U.S. cannabis market and the role that MSOS plays in providing access to this market. Key valuation metrics to consider include the ETF's net asset value (NAV) and its expense ratio. Growth considerations include the pace of state-level legalization, potential federal policy reform, and the overall performance of the U.S. cannabis companies held within the ETF. Investors should conduct their own due diligence and consider their risk tolerance before investing in MSOS.
What are the main risks for MSOS?
The main risks for MSOS are primarily related to the regulatory uncertainty surrounding the cannabis industry. Changes in cannabis laws at the state or federal level could significantly impact the performance of U.S. cannabis companies and, consequently, the value of MSOS. Other risks include market volatility, competition from other ETFs and investment vehicles, and negative public perception of the cannabis industry. Investors should also be aware of the potential for fluctuations in cannabis company valuations and changes in consumer preferences for cannabis products. These risks highlight the importance of careful due diligence and risk management when investing in MSOS.
What are the key factors to evaluate for MSOS?
AdvisorShares Pure US Cannabis ETF (MSOS) holds an AI score of 44/100 (low). Not financial advice.
How frequently does MSOS data refresh on this page?
MSOS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MSOS's recent stock price performance?
AdvisorShares Pure US Cannabis ETF (MSOS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: First U.S.-listed ETF focused exclusively on U.S. cannabis companies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MSOS overvalued or undervalued right now?
Valuing AdvisorShares Pure US Cannabis ETF (MSOS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MSOS?
Before investing in AdvisorShares Pure US Cannabis ETF (MSOS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The cannabis industry is subject to rapid regulatory changes, which could impact the performance of MSOS.
- Past performance is not indicative of future results.
- Investors should consult with a financial advisor before making investment decisions.